Summary:
Does the campaign against CAM indicate that powerful
factions feel threatened? A complacent CAM world has
been slow to collect supporting data, but the waning of
big pharma’s once unassailable economic and clinical
dominance may be a significant motivator for some who
oppose integration. With biotech innovation slowing
down, and adverse event scandals and research irregularities,
users are distrusting flagship revenue-producing medications. As healthcare policy reshapes mainstream medicine we will need to understand the forces ranged against integrated medicine